SIX1 Overexpression Predicts Poor Prognosis and Induces Radioresistance Through AKT Signaling in Esophageal Squamous Cell Carcinoma

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2017 Mar 7

PMID 28260921

Citations 17

Authors

Zheng He

Guang Li

Lingrong Tang

Yaming Li

Affiliations

Soon will be listed here.

Abstract

The Sineoculis homeobox homolog 1 (SIX1) protein has been found to be overexpressed in several human cancers. However, its expression pattern and biological roles in esophageal squamous cell carcinoma (ESCC) remain unexplored. This study examined the clinical significance of SIX1 in 119 ESCC tissues. It was found that SIX1 protein was upregulated in 36.9% (44/119) cases. SIX1 overexpression was an independent predictor for short survival of ESCC patients. siRNA knockdown and plasmid transfection were carried out in ESCC cell lines. SIX1 depletion inhibited cell growth, invasion, and colony formation, whereas its overexpression facilitated in vivo and in vitro cell growth, invasion, and colony formation. The apoptosis rate induced by X-ray irradiation was substantially increased by SIX1 knockdown in Eca-109 cells. Ectopic overexpression of SIX1 in TE-1 cells dramatically enhanced resistance to irradiation. Western blot analysis showed that SIX1 depletion downregulated cyclin E, matrix metalloproteinase-2 (MMP-2), Bcl-2 expression and upregulated Bim expression. SIX1 overexpression exhibited the opposite effect on these proteins. In addition, it was found that SIX1 could positively regulate extracellular signal-regulated kinase (ERK) and AKT signaling pathway. ERK inhibitor abolished the effect of SIX1 on MMP-2 expression. AKT inhibitor treatment blocked the role of SIX1 on anti-apoptotic protein Bcl-2. In conclusion, this study demonstrates that SIX1 overexpression predicts poor survival in ESCC patients and confers radioresistance through activation of AKT signaling pathways.

Citing Articles

Targeting sine oculis homeoprotein 1 (SIX1): A review of oncogenic roles and potential natural product therapeutics.

Bian Z, Benjamin M, Bialousow L, Tian Y, Hobbs G, Karan D Heliyon. 2024; 10(12):e33204.

PMID: 39022099 PMC: 11252760. DOI: 10.1016/j.heliyon.2024.e33204.

NEK2 contributes to radioresistance in esophageal squamous cell carcinoma by inducing protective autophagy via regulating TRIM21.

Guo D, Zhou S, Liu R, Yao W, Li S, Zhang X Cancer Cell Int. 2024; 24(1):179.

PMID: 38783335 PMC: 11112778. DOI: 10.1186/s12935-024-03367-5.

All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer.

Hughes C, Alderman C, Wolin A, Fields K, Zhao R, Ford H Biochim Biophys Acta Rev Cancer. 2024; 1879(3):189098.

PMID: 38555001 PMC: 11111358. DOI: 10.1016/j.bbcan.2024.189098.

Manzamine-A Alters In Vitro Calvarial Osteoblast Function.

Hardy S, Choo Y, Hamann M, Cray J Mar Drugs. 2022; 20(10).

PMID: 36286470 PMC: 9604769. DOI: 10.3390/md20100647.

Concurrent Chemoradiotherapy-Driven Cell Plasticity by miR-200 Family Implicates the Therapeutic Response of Esophageal Squamous Cell Carcinoma.

Lee Y, Lin C, Chang W, Lin W, Pan J, Wang W Int J Mol Sci. 2022; 23(8).

PMID: 35457185 PMC: 9030842. DOI: 10.3390/ijms23084367.

References

Behbakht K, Qamar L, Aldridge C, Coletta R, Davidson S, Thorburn A . Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival. Cancer Res. 2007; 67(7):3036-42. DOI: 10.1158/0008-5472.CAN-06-3755. View

Reichenberger K, Coletta R, Schulte A, Varella-Garcia M, Ford H . Gene amplification is a mechanism of Six1 overexpression in breast cancer. Cancer Res. 2005; 65(7):2668-75. DOI: 10.1158/0008-5472.CAN-04-4286. View

Watanabe H, Kurabayashi T, Miura M . Inhibition of the extracellular signal-regulated kinase (ERK) pathway and the induction of radioresistance in rat 3Y1 cells. Int J Radiat Biol. 2004; 80(6):451-7. DOI: 10.1080/09553000410001702355. View

Rochigneux P, Resbeut M, Rousseau F, Bories E, Raoul J, Poizat F . Radio(chemo)therapy in Elderly Patients with Esophageal Cancer: A Feasible Treatment with an Outcome Consistent with Younger Patients. Front Oncol. 2014; 4:100. PMC: 4026749. DOI: 10.3389/fonc.2014.00100. View

Mirkovic N, Voehringer D, Story M, McConkey D, McDonnell T, Meyn R . Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols. Oncogene. 1997; 15(12):1461-70. DOI: 10.1038/sj.onc.1201310. View

Park S, Kim Y, Ju E, Shin S, Choi J, Park J . Ibulocydine sensitizes human cancers to radiotherapy by induction of mitochondria-mediated apoptosis. Radiother Oncol. 2014; 112(2):295-301. DOI: 10.1016/j.radonc.2014.07.005. View

Azria D, Ozsahin M, Kramar A, Peters S, Atencio D, Crompton N . Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res. 2008; 14(19):6284-8. PMC: 2771757. DOI: 10.1158/1078-0432.CCR-08-0700. View

Chen J, Yang H, Wen J, Luo K, Liu Q, Huang Y . NHE9 induces chemoradiotherapy resistance in esophageal squamous cell carcinoma by upregulating the Src/Akt/β-catenin pathway and Bcl-2 expression. Oncotarget. 2015; 6(14):12405-20. PMC: 4494947. DOI: 10.18632/oncotarget.3618. View

Ramalingam M, Kim S . Insulin involved Akt/ERK and Bcl-2/Bax pathways against oxidative damages in C6 glial cells. J Recept Signal Transduct Res. 2014; 36(1):14-20. DOI: 10.3109/10799893.2014.970276. View

10.

Radisky D . Defining a role for the homeoprotein Six1 in EMT and mammary tumorigenesis. J Clin Invest. 2009; 119(9):2528-31. PMC: 2735897. DOI: 10.1172/JCI40555. View

11.

Zingg U, Montani M, Frey D, Dirnhofer S, Went P, Oertli D . Influence of neoadjuvant radio-chemotherapy on tumor-infiltrating lymphocytes in squamous esophageal cancer. Eur J Surg Oncol. 2009; 35(12):1268-72. DOI: 10.1016/j.ejso.2009.07.002. View

12.

Wang F, Qi Y, Li X, He W, Fan Q, Zong H . HDAC inhibitor trichostatin A suppresses esophageal squamous cell carcinoma metastasis through HADC2 reduced MMP-2/9. Clin Invest Med. 2013; 36(2):E87-94. DOI: 10.25011/cim.v36i2.19571. View

13.

Liu Y, Chakroun I, Yang D, Horner E, Liang J, Aziz A . Six1 regulates MyoD expression in adult muscle progenitor cells. PLoS One. 2013; 8(6):e67762. PMC: 3695946. DOI: 10.1371/journal.pone.0067762. View

14.

Zheng X, Liang P, Guo J, Zheng Y, Han J, Yu L . Expression and clinical implications of homeobox gene Six1 in cervical cancer cell lines and cervical epithelial tissues. Int J Gynecol Cancer. 2011; 20(9):1587-92. View

15.

Chen B, Kim E, Xu P . Initiation of olfactory placode development and neurogenesis is blocked in mice lacking both Six1 and Six4. Dev Biol. 2008; 326(1):75-85. PMC: 7058120. DOI: 10.1016/j.ydbio.2008.10.039. View

16.

Shimura T, Noma N, Sano Y, Ochiai Y, Oikawa T, Fukumoto M . AKT-mediated enhanced aerobic glycolysis causes acquired radioresistance by human tumor cells. Radiother Oncol. 2014; 112(2):302-7. DOI: 10.1016/j.radonc.2014.07.015. View

17.

Qin Y, Zhang Q, Lee S, Zhong W, Liu Y, Liu H . Doxycycline reverses epithelial-to-mesenchymal transition and suppresses the proliferation and metastasis of lung cancer cells. Oncotarget. 2015; 6(38):40667-79. PMC: 4747360. DOI: 10.18632/oncotarget.5842. View

18.

Ikeda K, Kageyama R, Suzuki Y, Kawakami K . Six1 is indispensable for production of functional progenitor cells during olfactory epithelial development. Int J Dev Biol. 2011; 54(10):1453-64. DOI: 10.1387/ijdb.093041ki. View

19.

Smith A, Iwanaga R, Drasin D, Micalizzi D, Vartuli R, Tan A . The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene. 2012; 31(50):5162-71. PMC: 3342483. DOI: 10.1038/onc.2012.11. View

20.

Nord H, Nygard Skalman L, von Hofsten J . Six1 regulates proliferation of Pax7-positive muscle progenitors in zebrafish. J Cell Sci. 2013; 126(Pt 8):1868-80. DOI: 10.1242/jcs.119917. View